A Review on: Bioanayltical Method Development and Validation
DOI:
https://doi.org/10.22270/ajprd.v13i3.1578Abstract
The creation of selective, sensitive, and reliable bioanalytical methods for accurately quantifying drugs and their metabolites in biological samples is a critical component of successful drug development. These methods ensure that the analytical processes used are suitable for biomedical purposes. Bioanalytical method validation encompasses a series of procedures designed to confirm that a method employed for quantifying analytes in biological matrices like blood, plasma, serum, or urine is dependable and consistent for its intended applications.The data derived from such methods is essential for regulatory submissions, including investigational new drug applications (INDs), new drug applications (NDAs), abbreviated new drug applications (ANDAs), biologic license applications (BLAs), and their respective supplements. These validated methods play a vital role in human clinical pharmacology, bioavailability (BA), and bioequivalence (BE) studies, which require accurate evaluation of pharmacokinetic, toxicokinetic, or biomarker concentrations.Therefore, it is crucial to ensure that bioanalytical methods are carefully developed, thoroughly validated, and documented to meet the required standards, ensuring reliable results in drug analysis. High-performance liquid chromatography (HPLC) is a versatile analytical technique, particularly beneficial for identifying and quantifying low concentrations of drugs and metabolites in biological matrices. As such, developing and validating HPLC-based bioanalytical methods for low-dose drugs offers significant advantages.This article highlights advancements in HPLC-based bioanalytical method development and validation for various drugs, emphasizing their documentation and applications.
Downloads
References
Moein MM, El Beqqali A, Abdel-Rehim M. Bioanalytical method development and validation: Critical concepts and strategies. J chromatography B. 2017 Feb 1;1043:3-11.
Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC–MS/MS assays: evaluation of matrix effects. J chromatography B. 2009 Aug 1;877(23):2198-207.
González O, Blanco ME, Iriarte G, Bartolomé L, Maguregui MI, Alonso RM. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. J chromatography A. 2014 Aug 1;1353:10-27.
Zimmer D. Introduction to quantitative liquid chromatography-tandem mass spectrometry (LC-MS-MS). Chromatographia. 2003 Jan;57(Suppl):S325-32.
Sonawane LV, Poul BN, Usnale SV, Waghmare PV, Surwase LH. Bioanalytical method validation and its pharmaceutical application—a review. Pharm Anal Acta. 2014 Apr;5(288):2.
Sankar PR, Geethika AS, Rachana G, Babu PS, Bhargavi J. Bioanalytical method validation: A comprehensive review. Int J Pharm Sci Rev Res. 2019;9:50-8.
Findlay JW, Smith WC, Lee JW, Nordblom GD, Das I, DeSilva BS, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000 Jan 1;21(6):1249-73.
Nakashima K. High-performance liquid chromatographic analysis of drugs of abuse in biologic samples. J Health Sci. 2005;51(3):272-7.
Pushpa Latha E, Sailaja B. Bioanalytical method development and validation by HPLC: a review. J Appl Pharm. 2013 Dec;1:1-9.
Chandramouli R, Kumar P, Bibhishan KV. Analytical method development and validation for pre-clinical analysis. J Pharm Sci Res. 2010 Dec 1;2(12):795.
Bonate PL, Howard DR, editors. Pharmacokinetics in drug development: regulatory and development paradigms. New York: Springer Science & Business Media; 2004 Dec 5.
Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci. 1992 Nov 1;17(11):463-8.
Kwon Y. Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists. New York: Springer Science & Business Media; 2001 Dec 31.
Watt AP, Morrison D, Evans DC. Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery. Drug Discov Today. 2000 Jan 1;5(1):17-24.
Wal P, Kumar B, Bhandari A, Rai AK, Wal A. Bioanalytical method development–Determination of drugs in biological fluids. J Pharm Sci Technol. 2010;2(10):33.
Rahman A. Bioanalytical method development, validation and techniques used for pharmacokinetic studies using LC-MS/MS. Contemp Investig Observ Pharm. 2012;1(2):63-71.
Krishnan TR, Ibraham I. Solid-phase extraction technique for the analysis of biological samples. J Pharm Biomed Anal. 1994 Mar 1;12(3):287-94.
Murugan S, Elayaraja A, Chandrakala K, Ramaiah P, Vulchi C. A review on method development and validation by using HPLC. Int J Novel Trends Pharm Sci. 2013 Jul 10;3(4):78-81.
LK T, NT R, UN M. A review on bioanalytical method development and validation. Asian J Pharm Clin Res. 2016;9(3):6-10.
Bakes D. Strategy for the development of quantitative analytical procedures. In: Lee JW, editor. Principles and Practice of Bioanalysis. Boca Raton: CRC Press; 2003 Jun 22. p. 359-75.
Wells DA. High throughput bioanalytical sample preparation—methods and automation strategies. Prog Pharm Biomed Anal. 2003.
Kupiec T. Quality-control analytical methods: High-performance liquid chromatography. Int J Pharm Compd. 2004 May 1;8:223–7.
Khairnar KV, Mahamuni AP, Babalsure AV, Udbale SV, Panchal CV. A review on HPLC method development and validation.
Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method development. New York: John Wiley & Sons; 1997 Dec 3.
Shah VP. The history of bioanalytical method validation and regulation: evolution of a guidance document on bioanalytical methods validation. AAPS J. 2007 Mar;9(1):E43.
Karnes HT, Shiu G, Shah VP. Validation of bioanalytical methods. Pharm Res. 1991 Apr; 8:421–6.
U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Bioanalytical method validation. Center for Drug Evaluation and Research (CDER); Center for Veterinary Medicine (CVM).
Tiwari G, Tiwari R. Bioanalytical method validation: An updated review. Pharm Methods. 2010 Oct 1;1(1):25–38.
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res. 2000 Dec;17:1551–7.
Gao L, Li J, Kasserra C, Song Q, Arjomand A, Hesk D, et al. Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies. Anal Chem. 2011 Jul 15;83(14):5607–16.
James CA, Breda M, Frigerio E. Bioanalytical method validation: a risk-based approach?. J Pharm Biomed Anal. 2004 Jun 29;35(4):887–93.
[No authors listed]. SOP 12: Validation of bioanalytical methods. Onkologie. 2003;26 Suppl 6:52–5.
Gilbert MT, Barinov-Colligon I, Miksic JR. Cross-validation of bioanalytical methods between laboratories. J Pharm Biomed Anal. 1995 Apr 1;13(4-5):385–94.
Rozet E, Dewé W, Morello R, Chiap P, Lecomte F, Ziemons E, et al. Risk-based approach for the transfer of quantitative methods: Bioanalytical applications. J Chromatogr A. 2008 May 2;1189(1-2):32–41.
Patil S, Pandurang ND, Kuchekar BS. Bioanalytical method development and validation: Guidelines latest reviews. Pharmainfo.net. 2009;7:1–8.
Singh UK, Pandey S, Pandey P, Keshri PK, Wal P. Bioanalytical method development and validation. Express Pharma. 2008;2:1–8.
Hartmann C, Massart DL, McDowall RD. An analysis of the Washington Conference Report on bioanalytical method validation. J Pharm Biomed Anal. 1994 Nov 1;12(11):1337–43.
Causon R. Validation of chromatographic methods in biomedical analysis: viewpoint and discussion. J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):175–80.
Buick AR, Doig MV, Jeal SC, Land GS, McDowall RD. Method validation in the bioanalytical laboratory. J Pharm Biomed Anal. 1990 Jan 1;8(8-12):629–37.
Tur F, Tur E, Lentheric I, Mendoza P, Encabo M, Isern B, et al. Validation of an LC–MS bioanalytical method for quantification of phytate levels in rat, dog and human plasma. J Chromatogr B. 2013 Jun 1;928:146–54.
Gil J, Cabrales A, Reyes O, Morera V, Betancourt L, Sánchez A, et al. Development and validation of a bioanalytical LC–MS method for the quantification of GHRP-6 in human plasma. J Pharm Biomed Anal. 2012 Feb 23;60:19–25.
Lang JR, Bolton S. A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry—1. Experimental considerations. J Pharm Biomed Anal. 1991 Jan 1;9(5):357–61.
Causon R. Validation of chromatographic methods in biomedical analysis viewpoint and discussion. J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):175–80. Rozet E, Marini RD, Ziemons E, Boulanger B, Hubert P. Advances in validation, risk and uncertainty assessment of bioanalytical
methods. J Pharm Biomed Anal. 2011 Jun 25;55(4):848–61.
Boulanger B, Rozet E, Moonen F, Rudaz S, Hubert P. A risk-based analysis of the AAPS conference report on quantitative bioanalytical methods validation and implementation. J Chromatogr B. 2009 Aug 1;877(23):2235–43.
Pandey S, Pandey P, Tiwari G, Tiwari R. Bioanalysis in drug discovery and development. Pharm Methods. 2010 Oct 1;1(1):14–24.
Nováková L. Challenges in the development of bioanalytical liquid chromatography–mass spectrometry method with emphasis on fast analysis. J Chromatogr A. 2013 May 31;1292:25–37.
Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int. 2007 Jan 17;165(2-3):216–24.
McPolin O. Validation of analytical methods for pharmaceutical analysis. Morrisville: Lulu.com; 2009 May 1.
DeSilva B, Smith W, Weiner R, Kelley M, Smolec J, Lee B, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003 Nov;20:1885–900.
Kelley M, DeSilva B. Key elements of bioanalytical method validation for macromolecules. AAPS J. 2007 Jun;9:E156–63.
Braggio S, Barnaby RJ, Grossi P, Cugola M. A strategy for validation of bioanalytical methods. J Pharm Biomed Anal. 1996 Feb 1;14(4):375–88.
Karnes HT, Shiu G, Shah VP. Validation of bioanalytical methods. Pharm Res. 1991 Apr;8:421–6.
Blume H, Brendel E, Brudny-Klöppel M, Grebe S, Lausecker B, Rohde G, et al. Workshop/conference report on EMA draft guideline on validation of bioanalytical methods. Eur J Pharm Sci. 2011 Feb 14;42(3):300–5.
Chau CH, Rixe O, McLeod H, Figg WD. Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res. 2008 Oct 1;14(19):5967–76.
Kalakuntla RR, Kumar KS. Bioanalytical method validation: A quality assurance auditor viewpoint. J Pharm Sci Res. 2009 Sep 1;1(3):1.
Dadgar D, Burnett PE, Choc MG, Gallicano K, Hooper JW. Application issues in bioanalytical method validation, sample analysis and data reporting. J Pharm Biomed Anal. 1995 Feb 1;13(2):89–97.
Singtoroj T, Tarning J, Annerberg A, Ashton M, Bergqvist Y, White NJ, et al. A new approach to evaluate regression models during validation of bioanalytical assays. J Pharm Biomed Anal. 2006 Apr 11;41(1):219–27.
Sekar V, Jayaseelan S, Subash N, Udhaya KE, Perumal P, Venkatesh RP. Bioanalytical method development and validation of letrozole by RP-HPLC method. Int J Periodont Restor Dent. 2009;1:1–7.
Dawes ML, Bergum JS, Schuster AE, Aubry AF. Application of a design of experiment approach in the development of a sensitive bioanalytical assay in human plasma. J Pharm Biomed Anal. 2012 Nov 1;70:401–7.
Goncalves D, Alves G, Soares-da-Silva P, Falcao A. Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: A review. Anal Chim Acta. 2012;710:17–32.
Naudiyal R, Kumar P, Kothiyal P. Int J Univ Pharm Bio Sci.
Somthane PN, Shaikh IA, Bavage NB, Gali V, Bavage SB. Bioanalytical method validation and its pharmaceutical application—a review.
Behnisch PA, Hosoe K, Sakai SI. Bioanalytical screening methods for dioxins and dioxin-like compounds—a review of bioassay/biomarker technology. Environ Int. 2001 Nov 1; 27(5):413–39.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Suvarna V. Pawar, Dr. Vinayak M. Gaware
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.